Harmon C S相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours.

循环细胞因子和单核细胞亚群作为舒尼替尼治疗晚期神经内分泌肿瘤患者的疗效和生物活性的生物标志物

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/bjc.2015.73

Zurita A J, Khajavi M, Wu H-K, Tye L, Huang X, Kulke M H, Lenz H-J, Meropol N J, Carley W, DePrimo S E, Lin E, Wang X, Harmon C S, Heymach J V

免疫/内分泌

细胞生物学

发表日期：2015

文献求助收藏

Sunitinib in combination with docetaxel and prednisone in chemotherapy-naive patients with metastatic, castration-resistant prostate cancer: a phase 1/2 clinical trial

舒尼替尼联合多西他赛和泼尼松治疗既往未接受过化疗的转移性去势抵抗性前列腺癌患者：一项 1/2 期临床试验

期刊:Annals of Oncology

影响因子:65.4

doi:10.1093/annonc/mdr349

Zurita, A J; George, D J; Shore, N D; Liu, G; Wilding, G; Hutson, T E; Kozloff, M; Mathew, P; Harmon, C S; Wang, S L; Chen, I; Chow Maneval, E; Logothetis, C J

发表日期：2012

文献求助收藏

Regulation of fos-lacZ fusion gene expression in primary mouse epidermal keratinocytes isolated from transgenic mice

从转基因小鼠中分离的原代小鼠表皮角质形成细胞中fos-lacZ融合基因表达的调控

期刊:Biochemical Journal

影响因子:4.3

doi:10.1042/bj3000263

Bollag, W B; Xiong, Y; Ducote, J; Harmon, C S

细胞生物学

发表日期：1994

文献求助收藏